查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600887

糖化白蛋白檢測法市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖化白蛋白檢測法市場價值為2.1729億美元，預計到2024年將達到2.3269億美元，複合年成長率為7.51%，預計到2030年將達到3.6092億美元。

糖化白蛋白檢測法市場的定義是對測量糖化白蛋白水平以監測和管理糖尿病狀況的診斷測試的需求。對這些測試的需求源於它們在填補 HbA1c 測試留下的空白方面的作用，HbA1c 測試提供長期血糖值資料，並提供準確的短期血糖控制評估。這些測試對於患有影響紅血球壽命的疾病的患者或接受透析的患者特別有用。最終使用範圍主要是專注於糖尿病綜合管理和相關代謝疾病的醫院、診斷實驗室和研究機構。

主要市場統計
基準年[2023] 21729萬美元
預測年份 [2024] 23269萬美元
預測年份 [2030] 36092萬美元
複合年成長率（%） 7.51%

推動糖化白蛋白檢測法市場的關鍵成長要素包括全球糖尿病盛行率的不斷上升、人們對早期檢測方法的認知不斷提高，以及檢測試劑套件的技術進步，提高了準確性和易用性。在新興市場，糖尿病盛行率不斷上升，醫療基礎設施正在加強，以適應更先進的診斷工具，因此存在著增加採用的新機會。醫療機構和檢測開發商之間的合作可能會推動市場擴張，而專注於使用更快、更具成本效益的套件進行廣泛篩檢的產品開拓具有廣泛的成長潛力。

影響市場成長的挑戰和限制包括與檢測試劑套件相關的高成本以及與 HbA1c 等既定指標相比，醫療保健專業人員對糖化白蛋白檢測的認知較低。此外，一些地區的監管障礙可能會延遲新產品的市場進入。專注於降低成本、提高測量準確性的研究以及針對醫療保健專業人員的綜合教育計劃可能會解決這些障礙。

最佳創新領域包括整合數位健康平台和指標，以即時監測和管理糖尿病患者，以提高患者參與度和治療結果。由於市場競爭激烈，並且隨著技術進步而迅速發展，透過策略夥伴關係和檢測開發的持續創新，存在成長潛力。

市場動態：快速發展的糖化白蛋白檢測法市場的關鍵市場洞察

供需的動態交互作用正在改變糖化白蛋白檢測法市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球糖尿病盛行率上升
    • 政府針對早期糖尿病篩檢計畫的舉措
  • 市場限制因素
    • 糖化白蛋白檢測的技術局限性
  • 市場機會
    • 技術進步提高了測量技術的準確性和靈敏度
    • 就地檢驗(POCT) 的開發與擴展使用
  • 市場挑戰
    • 替代技術的意識和存在程度較低

波特五力：駕馭糖化白蛋白檢測法市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖化白蛋白檢測法市場的外部影響

外部宏觀環境因素在塑造糖化白蛋白檢測法市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解糖化白蛋白檢測法市場的競爭狀況

對糖化白蛋白檢測法市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣糖化白蛋白檢測法市場供應商的績效評估

FPNV定位矩陣是評估糖化白蛋白檢測法市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為糖化白蛋白檢測法市場的成功指明道路

對於旨在加強在全球市場的影響力的公司來說，糖化白蛋白檢測法市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的糖尿病盛行率正在上升
      • 政府關於早期糖尿病篩檢計畫的舉措
    • 抑制因素
      • Glico檢測的技術限制
    • 機會
      • 技術進步改進了分析方法，提高了準確性和靈敏度
      • 開發並增加 GA就地檢驗(POCT) 的使用
    • 任務
      • 對替代技術的認知和存在有限
  • 市場區隔分析
    • 產品：增加動物糖化白蛋白檢測法的使用，以了解疾病機制
    • 應用：糖化白蛋白檢測法廣泛應用於第1型糖尿病的檢測，以預防健康併發症。
    • 最終使用者：診斷實驗室中糖化白蛋白檢測法的高使用率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖化白蛋白檢測法市場：依產品

  • 動物糖化白蛋白檢測法
  • 人類糖化白蛋白檢測法

第7章糖化白蛋白檢測法市場：依應用分類

  • 糖尿病前期
  • 1型糖尿病
  • 2型糖尿病

第 8 章 糖化白蛋白檢測法市場：依最終用戶分類

  • 糖尿病護理中心
  • 診斷實驗室
  • 醫院/診所

第9章北美和南美糖化白蛋白檢測法市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區糖化白蛋白檢測法市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲糖化白蛋白檢測法市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • John Lewis 和 Randox 之間的開創性合作推出店內血液檢測以加強健康檢查
    • 印度控制糖尿病和高血壓的策略性舉措
    • 1 型糖尿病治療的進展：Enable Biosciences 推出採用 ADAP 技術的創新「Kit to Clinics」計劃
    • 生物技術領域的開創性創新：WRCP IIT 教員因生物技術津貼點火器的成就而獎勵
    • ELSA 研究：英國兒童第 1 型糖尿病早期檢測和管理的開創性研究
    • Precision Diabetes, Inc. 與 DxGen Corp. 合作，推出 Epithod AutoDx，徹底改變照護現場糖尿病檢測
    • EKF Diagnostics 推出 FDA核准的LucicaGlicoL檢測套組簡介
  • 戰略分析和建議
    • 艾博康
    • 旭化成株式會社
    • 康德樂
    • 迪亞酶實驗室有限公司
    • EKF 診斷控股有限公司
    • 埃派尼克斯診斷公司
    • 美國實驗室控股公司
    • 工業工業株式會社
    • 庫薩比歐科技有限公司
    • 賽默飛世爾科技有限公司

公司名單

  • Abbexa Limited
  • Abcam PLC
  • Abnova Corporation
  • AFG Bioscience LLC
  • Asahi Kasei Corporation
  • Beijing Jiuqiang Biotechnology Co., Ltd.
  • Biomatik Corporation
  • Cardinal Health, Inc.
  • Crystal Chem Inc.
  • Cusabio Technology LLC
  • Diazyme Laboratories, Inc.
  • DxGen Corp.
  • EKF Diagnostics Holdings
  • Epinex Diagnostics Inc.
  • Hzymes Biotech
  • Laboratory Corporation of America Holdings
  • LifeSpan BioSciences, Inc.
  • Merck KGaA
  • Novatein Biosciences Inc.
  • Sekisui Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific LLC
  • Weldon Biotech, Inc.
  • Wuhan Fine Biotech Co., Ltd.
Product Code: MRR-A579C431592C

The Glycated Albumin Assay Market was valued at USD 217.29 million in 2023, expected to reach USD 232.69 million in 2024, and is projected to grow at a CAGR of 7.51%, to USD 360.92 million by 2030.

The Glycated Albumin Assay market is defined by the demand for diagnostic tests that measure glycated albumin levels to monitor and manage diabetic conditions. The necessity of these assays arises from their role in providing accurate, short-term glycemic control assessments, bridging the gap left by HbA1c tests, which offer long-term glucose level data. These assays are particularly useful for patients with conditions that affect red blood cell lifespan or undergoing dialysis, where HbA1c might give skewed results. End-use scope primarily spans hospitals, diagnostic laboratories, and research institutions focusing on comprehensive diabetes management and related metabolic disorders.

KEY MARKET STATISTICS
Base Year [2023] USD 217.29 million
Estimated Year [2024] USD 232.69 million
Forecast Year [2030] USD 360.92 million
CAGR (%) 7.51%

Key growth factors driving the glycated albumin assay market include the increasing prevalence of diabetes globally, rising awareness for early detection methods, and technological advancements in assay kits improving accuracy and ease of use. Novel opportunities lie in expanding adoption across emerging markets where diabetes prevalence is climbing, and healthcare infrastructures are strengthening to accommodate more sophisticated diagnostic tools. Collaborations between healthcare institutions and assay developers could foster market expansion, while product development focusing on faster, more cost-effective kits for widespread screening poses promising growth potential.

Challenges and limitations impacting market growth include the high costs associated with assay kits and limited awareness amongst healthcare professionals about glycated albumin testing relative to more established metrics like HbA1c. Additionally, regulatory hurdles in different regions can delay market entry for newer products. Research focusing on reducing costs, improving assay accuracy, and comprehensive education programs directed at healthcare professionals could address these barriers.

Best areas of innovation include integrating digital health platforms with assay results for real-time monitoring and management of diabetic patients, thus enhancing patient engagement and outcomes. The market's nature is competitive and rapidly evolving with technological advancements, indicating potential for growth through strategic partnerships and continuous innovation in assay development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glycated Albumin Assay Market

The Glycated Albumin Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes worldwide
    • Government initiatives for early diabetes screening programs
  • Market Restraints
    • Technical limitations of glycated albumin testing
  • Market Opportunities
    • Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
    • Growing development and use of point-of-care testing (POCT) of GA
  • Market Challenges
    • Limited awareness and presence of alternative techniques

Porter's Five Forces: A Strategic Tool for Navigating the Glycated Albumin Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glycated Albumin Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glycated Albumin Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glycated Albumin Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glycated Albumin Assay Market

A detailed market share analysis in the Glycated Albumin Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glycated Albumin Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glycated Albumin Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glycated Albumin Assay Market

A strategic analysis of the Glycated Albumin Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glycated Albumin Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Abnova Corporation, AFG Bioscience LLC, Asahi Kasei Corporation, Beijing Jiuqiang Biotechnology Co., Ltd., Biomatik Corporation, Cardinal Health, Inc., Crystal Chem Inc., Cusabio Technology LLC, Diazyme Laboratories, Inc., DxGen Corp., EKF Diagnostics Holdings, Epinex Diagnostics Inc., Hzymes Biotech, Laboratory Corporation of America Holdings, LifeSpan BioSciences, Inc., Merck KGaA, Novatein Biosciences Inc., Sekisui Chemical Co., Ltd., Thermo Fisher Scientific Inc., Thomas Scientific LLC, Weldon Biotech, Inc., and Wuhan Fine Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glycated Albumin Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Animal Glycated Albumin Assay and Human Glycated Albumin Assay.
  • Based on Application, market is studied across Prediabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End User, market is studied across Diabetic Care Centres, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes worldwide
      • 5.1.1.2. Government initiatives for early diabetes screening programs
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of glycated albumin testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
      • 5.1.3.2. Growing development and use of point-of-care testing (POCT) of GA
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and presence of alternative techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing use of animal glycated albumin assay to understand disease mechanisms
    • 5.2.2. Application: Significant adoption of glycated albumin assay for detection of type 1 diabetes owing to prevent health complications
    • 5.2.3. End User: High usage of glycated albumin assay in diagnostic laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glycated Albumin Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Animal Glycated Albumin Assay
  • 6.3. Human Glycated Albumin Assay

7. Glycated Albumin Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Prediabetes
  • 7.3. Type 1 Diabetes
  • 7.4. Type 2 Diabetes

8. Glycated Albumin Assay Market, by End User

  • 8.1. Introduction
  • 8.2. Diabetic Care Centres
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics

9. Americas Glycated Albumin Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycated Albumin Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Albumin Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Pioneering Partnership Between John Lewis and Randox Unveils In-Store Blood Testing to Enhance Health Diagnostics
    • 12.3.2. Strategic Initiatives to Combat Diabetes and Hypertension in India
    • 12.3.3. Advancing Type 1 Diabetes Care: Enable Biosciences Launches Innovative 'Kit to Clinics' Program Featuring ADAP Technology
    • 12.3.4. Pioneering Innovations in Biotechnology: Recognizing the Achievements of WRCP IIT Faculty in Securing Biotechnology Ignition Grants
    • 12.3.5. ELSA Study: Pioneering Early Detection and Management of Type 1 Diabetes in UK Children
    • 12.3.6. Precision Diabetes, Inc. Partners with DxGen Corp. to Revolutionize Point-of-Care Diabetes Testing with the Launch of Epithod AutoDx
    • 12.3.7. Introduction of the FDA-Cleared Lucica Glycated Albumin-L Test Kit by EKF Diagnostics
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Abcam PLC
    • 12.4.2. Asahi Kasei Corporation
    • 12.4.3. Cardinal Health, Inc.
    • 12.4.4. Diazyme Laboratories, Inc.
    • 12.4.5. EKF Diagnostics Holdings PLC
    • 12.4.6. Epinex Diagnostics Inc.
    • 12.4.7. Laboratory Corporation of America Holdings
    • 12.4.8. Sekisui Chemical Co., Ltd.
    • 12.4.9. Cusabio Technology LLC
    • 12.4.10. Thermo Fisher Scientific Inc.

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abcam PLC
  • 3. Abnova Corporation
  • 4. AFG Bioscience LLC
  • 5. Asahi Kasei Corporation
  • 6. Beijing Jiuqiang Biotechnology Co., Ltd.
  • 7. Biomatik Corporation
  • 8. Cardinal Health, Inc.
  • 9. Crystal Chem Inc.
  • 10. Cusabio Technology LLC
  • 11. Diazyme Laboratories, Inc.
  • 12. DxGen Corp.
  • 13. EKF Diagnostics Holdings
  • 14. Epinex Diagnostics Inc.
  • 15. Hzymes Biotech
  • 16. Laboratory Corporation of America Holdings
  • 17. LifeSpan BioSciences, Inc.
  • 18. Merck KGaA
  • 19. Novatein Biosciences Inc.
  • 20. Sekisui Chemical Co., Ltd.
  • 21. Thermo Fisher Scientific Inc.
  • 22. Thomas Scientific LLC
  • 23. Weldon Biotech, Inc.
  • 24. Wuhan Fine Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLYCATED ALBUMIN ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLYCATED ALBUMIN ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCATED ALBUMIN ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY ANIMAL GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HUMAN GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIABETIC CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023